Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
V-Zhi Pharmaceutical is a comprehensive pharmaceutical group based in Shandong, China, specializing in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and finished dosage forms. The company operates a vertically integrated business model covering the entire value chain from chemical intermediates to high-end generic drugs. Its product portfolio primarily focuses on cardiovascular, metabolic, and anti-infective therapeutic areas, with a significant emphasis on high-barrier generics. Additionally, V-Zhi provides CDMO services to global partners, leveraging its large-scale manufacturing facilities and R&D centers in both China and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong V-Zhi Zhike Pharmaceutical.